Biotech Values

[exwannabe]

I would also expect that if this anti-PS antibody was really working, you'd expect bleeding as a mechanistic side effect in patients. Activated platelets expose phosphatidylserine to accelerate clotting (see ref). If anything, the antibody would inhibit this acceleration and decrease the efficiency of clotting.

So will we soon see a trial for Bavi for prevention of clots post hip replacement surgery?